Molecular docking and dynamics studies on propolis sulabiroin-A as a potential inhibitor of SARS-CoV-2

被引:63
作者
Fatriansyah, Jaka Fajar [1 ]
Rizqillah, Raihan Kenji [1 ]
Yandi, Muhamad Yusup [1 ]
Fadilah [2 ]
Sahlan, Muhamad [3 ]
机构
[1] Univ Indonesia, Fac Engn, Dept Met & Mat Engn, Kampus Depok, Jawa Barat 16424, Indonesia
[2] Univ Indonesia, Fac Med, Dept Med Chem, Jakarta 10430, Indonesia
[3] Univ Indonesia, Fac Engn, Dept Chem Engn, Kampus Depok, Jawa Barat 16424, Indonesia
关键词
SARS-CoV-2; Molecular docking; Molecular dynamics; Drug discovery; Sulabiroin-A; ULTRASOUND-ASSISTED EXTRACTION; ANTIVIRAL ACTIVITY; HESPERIDIN; QUERCETIN; EFFICACY; VIRUS;
D O I
10.1016/j.jksus.2021.101707
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Molecular docking and dynamics simulations were conducted to investigate the antiviral activity of Propolis Sulabiroin-A to inhibit the SARS-CoV-2 virus with quercetin, hesperidin, and remdesivir as control ligands. The parameters calculated were docking score and binding energy/molecular mechanicsgeneralized born surface area (MMGBSA), root mean square displacement (RMSD), and root mean square fluctuation (RMSF). Docking and MMGBSA scores showed that all the ligands demonstrate an excellent candidate as an inhibitor, and the order of both scores is hesperidin, remdesivir, quercetin, and sulabiroin-A. The molecular dynamics simulation showed that all the ligands are good candidates as inhibitors. Although the fluctuation of Sulabiroin-A is relatively high, it has less protein-ligand interaction time than other ligands. Overall, there is still a good possibility that sulabiroin-A can be used as an alternative inhibitor if a new structure of receptor SARS-CoV-2 is used. (c) 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:9
相关论文
共 34 条
[1]   Antimicrobial and immunomodulating activities of hesperidin and ellagic acid against diarrheic Aeromonas hydrophila in a murine model [J].
Abuelsaad, Abdelaziz S. A. ;
Mohamed, Imad ;
Allam, Gamal ;
Al-Solumani, Adnan A. .
LIFE SCIENCES, 2013, 93 (20) :714-722
[2]   Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs [J].
Anand, K ;
Ziebuhr, J ;
Wadhwani, P ;
Mesters, JR ;
Hilgenfeld, R .
SCIENCE, 2003, 300 (5626) :1763-1767
[3]   Quercetin derivatives as non-nucleoside inhibitors for dengue polymerase: molecular docking, molecular dynamics simulation, and binding free energy calculation [J].
Anusuya, Shanmugam ;
Gromiha, M. Michael .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2017, 35 (13) :2895-2909
[4]   Identification of dengue viral RNA-dependent RNA polymerase inhibitor using computational fragment-based approaches and molecular dynamics study [J].
Anusuya, Shanmugam ;
Velmurugan, Devadasan ;
Gromiha, M. Michael .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2016, 34 (07) :1512-1532
[5]   Review of the biological properties and toxicity of bee propolis (propolis) [J].
Burdock, GA .
FOOD AND CHEMICAL TOXICOLOGY, 1998, 36 (04) :347-363
[6]  
Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI [10.1056/NEJMoa2001282, 10.1056/NEJMc2008043]
[7]  
Cavasotto C.N., 2015, In silico drug discovery and design: theory, methods, challenges, and applications
[8]  
Chang Y., 2020, POTENTIAL THERAPEUTI, DOI [DOI 10.20944/PREPRINTS202002.0242.V1, 10.20944/preprints202002.0242.v1]
[9]   Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies [J].
Gao, Jianjun ;
Tian, Zhenxue ;
Yang, Xu .
BIOSCIENCE TRENDS, 2020, 14 (01) :72-73
[10]   The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities [J].
Genheden, Samuel ;
Ryde, Ulf .
EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (05) :449-461